Pharmaceutical M&A was again a feature of news last week. Announcing the first February acquisition was Horizon Therapeutics, which made a $3.05 billion offer for Viela Bio. The was followed by Jazz Pharmaceuticals bidding $7.2 billion for UK-based neuroscience firm GW Pharmaceuticals and its cannabinoid drug Epidiolex, which is the biggest deal so far this year. Elsewhere, Johnson & Johnson and Novavax both released new data on their respective COVID-19 vaccine candidates. 7 February 2021